Retatrutide — the triple-agonist purity question.

No — as of mid-2026, Retatrutide is still in late-stage Eli Lilly clinical trials (Phase 3 for obesity and Type 2 diabetes). All Retatrutide material currently available outside the Lilly clinical-trial supply chain is research-use-only material from compounding pharmacies or research-peptide vendors. Our testing is appropriate for research material — we are not a substitute for FDA-regulated supply-chain controls.

Sequence length and pharmacophore complexity. Semaglutide is single-agonist, ~31 residues. Tirzepatide is dual-agonist, 39 residues with a methionine residue prone to oxidation. Retatrutide is triple-agonist, 39 residues with a more complex modified side chain. From an HPLC + MS perspective the methods are identical; what changes is the impurity profile — Retatrutide has the most truncation peaks because of the longer / more-modified synthesis. We tune the HPLC gradient specifically to resolve those near-main-peak related substances.

We see 65-86 % NPC across research-peptide-vendor Retatrutide submissions, with a median around 78 %. Above 82 % is good quality. Below 70 % usually indicates excess counter-ion or residual lyophilization water — the vial labeled '10 mg' really only has ~6.8 mg of active. The NPC is independent of HPLC purity — a vial can be 99 % HPLC purity and only 72 % NPC.

Yes by LC-MS. The molecular ion mass and charge-state envelope are specific to the published Retatrutide structure; substitutions, deletions, or unrelated tri-agonist analogs have different observed masses. We catch this on the Identity + Potency panel ($499). For ambiguous cases we'll add MS/MS fragment-ion analysis at no charge.

Legally not required for research material, but the USP <71> sterility test is what separates injectable-grade from research powder. Most Retatrutide research material is reconstituted and injected — sterility matters in practice even if the regulatory label says 'research use only'. The 14-day culture method is included in Full Disclosure ($899).

Purity ($199): single 2 mg sealed lyophilized vial. Identity + Potency ($499): same single vial — we re-use dissolved material across HPLC, LC-MS, NPC, and TFA assays. Full Disclosure ($899): two additional vials for the destructive sterility and endotoxin tests. Ship by overnight courier with seal-integrity-intact packaging.